NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

TaiMed Biologics Inc (TWO: 4147)

 
4147 Technical Analysis
5
As on 21st Jan 2026 4147 STOCK Price closed @ 58.00 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 83.35 & Strong Sell for SHORT-TERM with Stoploss of 87.87 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

4147STOCK Price

Open 59.80 Change Price %
High 59.80 1 Day -1.80 -3.01
Low 57.50 1 Week -3.40 -5.54
Close 58.00 1 Month -9.10 -13.56
Volume 1357520 1 Year -24.00 -29.27
52 Week High 99.70 | 52 Week Low 58.00
 
TWO Taiwan Most Active Stocks
1815 104.50 -4.13%
6182 39.90 0.63%
3707 67.10 8.40%
5340 102.00 0.49%
5347 146.50 3.53%
4979 294.50 1.38%
4939 46.70 8.10%
3105 222.00 -2.20%
6217 61.00 -4.39%
5371 96.70 3.98%
 
TWO Taiwan Top Gainers Stocks
8933 8.80 10.00%
8277 10.80 9.98%
8277 10.80 9.98%
4171 21.50 9.97%
6126 37.65 9.93%
8074 72.00 9.92%
4533 32.15 9.91%
3234 51.10 9.89%
1569 56.90 9.85%
1569 56.90 9.85%
 
TWO Taiwan Top Losers Stocks
3264 148.50 -10.00%
3202 3.96 -10.00%
5351 62.50 -9.42%
3260 271.50 -8.89%
5291 35.00 -8.74%
5291 35.00 -8.74%
3372 23.70 -7.60%
5328 31.10 -7.44%
3221 25.45 -7.12%
6122 58.70 -6.38%
 
 
4147
Daily Charts
4147
Intraday Charts
Whats New @
Bazaartrend
4147
Free Analysis
 
4147 Important Levels Intraday
RESISTANCE62.43
RESISTANCE61.01
RESISTANCE60.13
RESISTANCE59.25
SUPPORT56.75
SUPPORT55.87
SUPPORT54.99
SUPPORT53.57
 
4147 Forecast January 2026
4th UP Forecast108.1
3rd UP Forecast92.03
2nd UP Forecast82.1
1st UP Forecast72.17
1st DOWN Forecast43.83
2nd DOWN Forecast33.9
3rd DOWN Forecast23.97
4th DOWN Forecast7.9
 
4147 Weekly Forecast
4th UP Forecast70.72
3rd UP Forecast66.64
2nd UP Forecast64.12
1st UP Forecast61.60
1st DOWN Forecast54.40
2nd DOWN Forecast51.88
3rd DOWN Forecast49.36
4th DOWN Forecast45.28
 
4147 Forecast2026
4th UP Forecast156.28
3rd UP Forecast124.76
2nd UP Forecast105.28
1st UP Forecast85.8
1st DOWN Forecast30.21
2nd DOWN Forecast10.72
3rd DOWN Forecast-8.76
4th DOWN Forecast-40.28
 
 
4147 Other Details
Segment EQ
Market Capital 17560358912.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
4147 Address
4147
 
4147 Latest News
 
Your Comments and Response on TaiMed Biologics Inc
 
4147 Business Profile
TaiMed Biologics Inc., a biotechnology company, develops, manufactures, and commercializes various drugs for the treatment and prevention of infectious diseases. The company develops and markets Ibalizumab (TMB-355) Intravenous Infusion, a humanized monoclonal antibody for the treatment of HIV-1 infection. It is also developing TMB-355 Intravenous Push, a humanized monoclonal antibody that is in Phase II clinical trials for the treatment of HIV-1 infection; TMB-355 Intramuscular Injection, a humanized monoclonal antibody intramuscular injection, which is in Phase II clinical trials for treating HIV-1; TMB-365, an anti-CD4 recombinant humanized monoclonal antibody, which is in Phase I clinical trials for treating HIV infections; TMB-370, a bispecific neutralizing antibody that is in Phase I clinical trials to treat HIV infections; and TMB-380, a neutralizing HIV-1 antibody. The company was founded in 2007 and is headquartered in Taipei, Taiwan. Address: No. 607, Ruiguang Road, Taipei, Taiwan, 11492
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service